GeneTether Therapeutics Company Description

GeneTether Therapeutics Inc., a biopharmaceutical company, focuses on the development of precision gene editing therapies based on its GeneTether platform for human therapeutics applications.

It is developing gene therapies for the treatment of patients with rare and monogenic kidney and skin diseases.

The company was founded in 2018 and is based in Kelowna, Canada.

GeneTether Therapeutics Inc.

Country	Canada
Founded	2018
Industry	Biotechnology
Sector	Healthcare
CEO	Roland Boivin

Contact Details

Address: 301 – 1665 Ellis Street Kelowna, British Columbia V1Y 2B3 Canada
Phone	514-796-2640
Website	genetether.com

Stock Details

Ticker Symbol	GTTX
Exchange	Canadian Securities Exchange
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	CA37187D1087
SIC Code	2834

Key Executives

Name	Position
Roland Boivin	Director and Chief Executive Officer
Dr. William James Garner M.D., M.P.H., MPH	Co-Founder and Executive Director
Jean M. Jen C.A., CPA	Chief Financial Officer and Corporate Secretary
Dr. R. Geoffrey Sargent Ph.D.	Co-Founder and Chief Scientific Officer